ArticleHelicobacter2022

Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.

Kazumi Inokuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.